Singapore markets open in 6 hours 35 minutes
Straits Times Index
3,332.80 -10.55 (-0.32%) S&P 500
5,460.48 -22.39 (-0.41%) Dow
39,118.86 -45.24 (-0.12%) Nasdaq
17,732.60 -126.10 (-0.71%) Bitcoin USD
61,623.31 +708.61 (+1.16%) CMC Crypto 200
1,280.39 -3.44 (-0.27%)
Lexaria Bioscience Corp. (LEXX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 39.91M |
| Enterprise value | 35.26M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 59.37 |
| Price/book (mrq) | 6.12 |
| Enterprise value/revenue | 87.13 |
| Enterprise value/EBITDA | -2.16 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.02 |
| 52-week change 3 | 270.67% |
| S&P500 52-week change 3 | 22.55% |
| 52-week high 3 | 6.8500 |
| 52-week low 3 | 0.7050 |
| 50-day moving average 3 | 3.0565 |
| 200-day moving average 3 | 2.1882 |
Share statistics
| Avg vol (3-month) 3 | 231.94k |
| Avg vol (10-day) 3 | 158.18k |
| Shares outstanding 5 | 14.32M |
| Implied shares outstanding 6 | 14.32M |
| Float 8 | 10.86M |
| % held by insiders 1 | 11.49% |
| % held by institutions 1 | 6.20% |
| Shares short (14 Jun 2024) 4 | 152.96k |
| Short ratio (14 Jun 2024) 4 | 0.54 |
| Short % of float (14 Jun 2024) 4 | 1.12% |
| Short % of shares outstanding (14 Jun 2024) 4 | 1.07% |
| Shares short (prior month 15 May 2024) 4 | 157.45k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 12 Jan 2021 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Aug 2023 |
| Most-recent quarter (mrq) | 29 Feb 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -460.69% |
Management effectiveness
| Return on assets (ttm) | -59.36% |
| Return on equity (ttm) | -101.49% |
Income statement
| Revenue (ttm) | 404.73k |
| Revenue per share (ttm) | 0.05 |
| Quarterly revenue growth (yoy) | 624.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -5.18M |
| Net income avi to common (ttm) | -5.44M |
| Diluted EPS (ttm) | -0.6700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.79M |
| Total cash per share (mrq) | 0.37 |
| Total debt (mrq) | 148.88k |
| Total debt/equity (mrq) | 2.42% |
| Current ratio (mrq) | 66.29 |
| Book value per share (mrq) | 0.53 |
Cash flow statement
| Operating cash flow (ttm) | -5.21M |
| Levered free cash flow (ttm) | -3.45M |
© 2024 Yahoo. All rights reserved.